Patent · US Active

Biodegradable particulate formulations

US9572894B2 · kind B2 · utility

1Cited by
1References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 18, 2011
Grant dateFeb 21, 2017
Priority date
Expiry dateNov 13, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/55561
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides three-component compositions comprising microparticles, a tumor antigen, a first immune adjuvant, and a second immune adjuvant. Also provided are chemo-immunotherapeutic compositions comprising microparticles, a chemotherapeutic agent, and an immune adjuvant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.